Home | Welcome to Contract Pharma   
Last Updated Thursday, June 20 2013
Print

Industry News

Related Searches:

Filter by:

September 5, 2012
Patheon to focus on core competencies   Read More »
September 5, 2012
Appoints business development director   Read More »
September 5, 2012
Supports Class 4 HPAPI’s   Read More »
September 4, 2012
Will make Prurisol for Phase II/III psoriasis trials   Read More »
September 4, 2012
Will focus on CNS Disorders   Read More »
September 4, 2012
To provide cell line development through maxXpress service   Read More »
August 31, 2012
Will pay $181 million to resolve claims   Read More »
August 30, 2012
To develop and commercialize daratumumab   Read More »
August 30, 2012
Provides GMP manufacturing services for research   Read More »
August 30, 2012
Completes first phase of global network plan   Read More »
August 29, 2012
$17 mil. deal adds to endotoxin, microbial portfolio   Read More »
August 29, 2012
Gains Aurangabad site from Orchid Chemicals   Read More »
August 29, 2012
Analysis shows unlikely to meet efficacy endpoint   Read More »
August 28, 2012
Biomanufacturing deal covers global Phase II-III trials   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On